INTRAVENOUS INFUSION OF STEROID AND TORENTAL FOR IDIOPATHIC SUDDEN SENSORINEURAL HEARING LOSS AMONG CASES IN AL-KHOMS TEACHING HOSPITAL, LIBYA
Ibrahim Genaw, Bioprabhu Sangar* and Bhaskara Rao Motamarri
ABSTRACT
Sudden hearing loss (SHL) is a frightening symptom that often prompts an urgent or emergent visit to a physician. Sudden Sensorineural Hearing loss (SSNHL) is the subset of SHL. Idiopathic sudden sensorineural hearing loss (ISSNHL) is defined as SSNHL with no identifiable cause despite adequate investigation. Objective of this study is to determine hearing recovery in patients with idiopathic sudden hearing loss treated with varying amount of IV infusion Hydrocortisone and Torental (Pentoxifylline) and an improvement of Quality of life among the Idiopathic sudden sensorineural hearing loss patients. A retrospective study was conducted at Al-khoms Teaching hospital, Al-khoms, Libya from October 2011 to September 2013. 75 cases (41 male and 34 females) with sudden hearing loss (Unilateral and or Bilateral) problems, between the age group of 20 and 89 were admitted in this study. The study were designed and grouped into two groups. Group1 with patients have received a course of IV infusion of Hydrocartisone (200mg) and Torental (Pentoxifiylline) 200mg for once in a day and group2 with patients have received a course of IV infusion of Hydrocortisone (200mg) and Torental (Pentoxifylline) 200mg for twice in a day. Use of steroid, Hydrocortisone and Torental (Pentoxyfylline) has improved the recovery of hearing more than 50% to normal. Torental has helped in speedy recovery by improving blood flow and oxygen. Intravenous infusion of drugs has added the value of recovery quickly which indirectly improved the quality of life among family, friends and Societies.
Keywords: Sudden sensorineural hearing loss, Hydrocortisone, Pentoxifylline.
[Download Article]
[Download Certifiate]